Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Oct 08, 2021 3:26pm
318 Views
Post# 33990151

When they wiped out retail investors 2 years ago and

When they wiped out retail investors 2 years ago andConverted their debt into equity part of their strategy re takeover then they kept a small loan on the books with multiple collateral attached to this loan

during 2019 agm when questioned Galbraith why they kept this loan he answered we didn't want to further dilute share ; lawyers have this on audio    This after they massively diluted shares  

this plus several other documented issues will come out during discovery ie questioning under oath 
<< Previous
Bullboard Posts
Next >>